Company intelligence / Profile preview

Prati-Donaduzzi

Toledo, Paraná, Brazilpratidonaduzzi.com.br ↗

Ownership: Private
Development stage: Commercial

Overview

Prati‑Donaduzzi is Brazil’s largest manufacturer of generic pharmaceuticals and the leading supplier to the Brazilian government. The company has a commercial portfolio covering a wide range of therapeutic areas with over five years’ experience in cannabinoid R&D. It has launched innovative cannabinoid-based medicines such as Myalo for refractory epilepsy, which has reached Phase III clinical trials. The company also maintains one of the largest production capacities in South America and supplies both domestic and global markets.

Therapeutic areas: OtherNeurology
Modalities: small molecules (generic drugs)synthetic cannabinoids (e.g., cannabidiol/CBD)natural cannabinoids (via partnership)
Industry: Biotech

Drug pipeline

1 asset

cannabidiol

Commercial

Indications: Multiple sclerosis, Chronic pain

Partnerships

Brains Bioceutical Corp. – supply agreement for EU-GMP natural CBD API used in clinical trials and commercialized cannabinoid products approved by ANVISA.

Beyond the preview

Go deeper on Prati-Donaduzzi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prati-Donaduzzi.

Explore the full profile